Single arm, open label, multi-institution study of RO5126766 (CH5127566) in patients with KRAS mutant NSCLC - Stand Up To Cancer

Blog

Posted January 22, 2020

Single arm, open label, multi-institution study of RO5126766 (CH5127566) in patients with KRAS mutant NSCLC

JOIN OUR COMMUNITY

Sign up to receive emails from Stand Up To Cancer.
   Please leave this field empty
Stand Up to Cancer

Thanks for signing up!
You will hear from us soon.